Yang, W., et al. (2020) The role of imaging in 2019 novel coronavirus pneumonia (COVID-19). European radiology 30: 1-9.
WHO. Weekly operational update on COVID-19 - 16 August 2021. 2021; Available from: https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19. 16 August 2021
Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3:237–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shang, J., et al., Structure of 2019-nCoV chimeric receptor-binding domain complexed with its receptor human ACE2. Worldw. Protein Data Bank (2020).
Shang J, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci. 2020;117(21):11727–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li F. Receptor recognition mechanisms of coronaviruses: a decade of structural studies. J Virol. 2015;89(4):1954–64.
Article
PubMed
CAS
Google Scholar
Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bahramali E, et al. Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case–control study. BMJ Open. 2016;6(2):e010282.
Article
PubMed
PubMed Central
Google Scholar
Sekuri C, et al. Renin-angiotensin system gene polymorphisms and premature coronary heart disease. J Renin Angiotensin Aldosterone Syst. 2005;6(1):38–42.
Article
CAS
PubMed
Google Scholar
Firouzabadi N, et al. Genetic variants of angiotensin-converting enzyme are linked to autism: a case-control study. PLoS ONE. 2016;11(4):e0153667.
Article
PubMed
PubMed Central
CAS
Google Scholar
Vaduganathan M, et al. Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382(17):1653–9.
Article
CAS
PubMed
Google Scholar
Ferrario CM. The renin-angiotensin system: importance in physiology and pathology. J Cardiovasc Pharmacol. 1990;15:S1-5.
Article
PubMed
Google Scholar
Li X, et al. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart. 2020;106(15):1142–7.
Article
CAS
PubMed
Google Scholar
Sabatino J, et al. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. PLoS ONE. 2020;15(8):1023.
Article
CAS
Google Scholar
Shamshirian, A., et al., Cardiovascular diseases and COVID-19 mortality and intensive care unit admission: A systematic review and meta-analysis. medRxiv, 2020.
Shenoy V, et al. The angiotensin-converting enzyme 2/angiogenesis-(1–7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med. 2010;182(8):1065–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wösten-van Asperen RM, et al. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1–7) or an angiotensin II receptor antagonist. J Pathol. 2011;225(4):618–27.
Article
PubMed
CAS
Google Scholar
Yan F, et al. Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients. Cell Discov. 2020;6(1):1–10.
Article
Google Scholar
Yang, G., et al., Angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors usage is associated with improved inflammatory status and clinical outcomes in COVID-19 patients with hypertension. MedRxiv, 2020.
Sun, M., et al., Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Zhonghua jie he he hu xi za zhi= Zhonghua jiehe he huxi zazhi= Chinese journal of tuberculosis and respiratory diseases, 2020. 43:E014-E014.
Wu J, et al. Advances in research on ACE2 as a receptor for 2019-nCoV. Cell Mol Life Sci. 2021;78(2):531–44.
Article
CAS
PubMed
Google Scholar
Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562–9.
Article
CAS
PubMed
Google Scholar
Costa LB, et al. Insights on SARS-CoV-2 molecular interactions with the renin-angiotensin system. Front Cell Dev Biol. 2020;8:55.
Article
Google Scholar
Hamming I, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol J Pathol Soc Great Britain Ireland. 2004;203(2):631–7.
CAS
Google Scholar
Donoghue M, et al. A novel angiotensin-converting enzyme–related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000;87(5):e1–9.
Article
CAS
PubMed
Google Scholar
Vickers C, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277(17):14838–43.
Article
CAS
PubMed
Google Scholar
Chappel M, Ferrario C. ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1–7). Kidney Int. 2006;70(1):8–10.
Article
CAS
PubMed
Google Scholar
Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020;46(6):1105–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu Z, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020;92(6):595–601.
Article
CAS
PubMed
Google Scholar
Liu Y, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nukiwa T, et al. Responses of serum and lung angiotensin-converting enzyme activities in the early phase of pulmonary damage induced by oleic acid in dogs. Am Rev Respir Dis. 1982;126(6):1080–6.
CAS
PubMed
Google Scholar
Dandona P, et al. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J Hum Hypertens. 2007;21(1):20–7.
Article
CAS
PubMed
Google Scholar
Liu F, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wiese O, Allwood B, Zemlin A. COVID-19 and the renin-angiotensin system (RAS): A spark that sets the forest alight? Med Hypotheses. 2020;144:110231.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chaoxin J, et al. The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease. Eur Rev Med Pharmacol Sci. 2013;17(19):2654–9.
CAS
PubMed
Google Scholar
Gemmati D, Tisato V. Genetic hypothesis and pharmacogenetics side of renin-angiotensin-system in COVID-19. Genes. 2020;11(9):1044.
Article
CAS
PubMed Central
Google Scholar
Alimoradi N, Firouzabadi N. impact of genetics on predisposition and prognosis of COVID-19. Trends Pharmaceut Sci. 2021;7(2):10.
Google Scholar
Barash A, et al. The pursuit of COVID-19 biomarkers: putting the spotlight on ACE2 and TMPRSS2 regulatory sequences. Front Med. 2020;7:10.
Article
Google Scholar
Srivastava A, et al. Genetic association of ACE2 rs2285666 polymorphism with COVID-19 spatial distribution in India. Front Genet. 2020;11:1163.
Article
Google Scholar
Çelik, S.K., et al., Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19; a case study. J Med Virol 2021.
Patel SK, et al. From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension. Front Physiol. 2014;5:227.
Article
PubMed
PubMed Central
Google Scholar
Calcagnile M, et al. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein. Biochimie. 2021;180:143–8.
Article
CAS
PubMed
Google Scholar
Ashoor, D., et al., A computational approach to evaluate the combined effect of SARS-CoV-2 RBD mutations and ACE2 receptor genetic variants on infectivity: The COVID-19 host-pathogen nexus. bioRxiv, 2021: p. 2020.10. 23.352344.
Pouladi N, Abdolahi S. Investigating the ACE2 polymorphisms in COVID-19 susceptibility: an in silico analysis. Mol Genet Genomic Med. 2021;10:e1672.
Google Scholar
Firouzabadi N, et al. Interaction of A-240T and A2350G related genotypes of angiotensin-converting enzyme (ACE) is associated with decreased serum ACE activity and blood pressure in a healthy Iranian population. Eur J Pharmacol. 2011;668(1–2):241–7.
Article
CAS
PubMed
Google Scholar
Firouzabadi N, et al. Association of angiotensin-converting enzyme (ACE) gene polymorphism with elevated serum ACE activity and major depression in an Iranian population. Psychiatry Res. 2012;200(2–3):336–42.
Article
CAS
PubMed
Google Scholar
Zhu X, et al. Linkage and association analysis of angiotensin I–converting enzyme (ACE)–gene polymorphisms with ACE concentration and blood pressure. Am J Human Genet. 2001;68(5):1139–48.
Article
CAS
Google Scholar
COVID-19 Clinical management: living guidance. 2021; Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1.
Leger T, et al. Low-dose chest CT for diagnosing and assessing the extent of lung involvement of SARS-CoV-2 pneumonia using a semi quantitative score. PLoS ONE. 2020;15(11):e0241407.
Article
CAS
PubMed
PubMed Central
Google Scholar
MWer S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
Article
Google Scholar
Zhong J, et al. Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. J Lab Clin Med. 2006;147(2):91–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Iqbal MP, et al. Association study of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with myocardial infarction. Exp Mol Med. 2004;36(2):110–5.
Article
CAS
PubMed
Google Scholar
Firouzabadi N, et al. Impact of ACE 2 genetic variant on antidepressant efficacy of SSRIs. Acta Neuropsychiatrica. 2021;10:1–25.
Google Scholar
Firouzabadi N, et al. Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease. Mol Biol Rep. 2013;40(8):4959–65.
Article
CAS
PubMed
Google Scholar
Kuba K, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat Med. 2005;11(8):875–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang, Q., et al., Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell, 2020;181(4):894–904. e9.
Santos RAS, et al. The ACE2/angiotensin-(1–7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1–7). Physiol Rev. 2017;98:505–53.
Article
PubMed Central
CAS
Google Scholar
Xu H, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):1–5.
Article
CAS
Google Scholar
Rice GI, et al. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004;383(1):45–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li Y, et al. Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways. Sci Rep. 2016;6(1):1–14.
CAS
Google Scholar
Magalhaes GS, et al. Angiotensin-(1–7) promotes resolution of eosinophilic inflammation in an experimental model of asthma. Front Immunol. 2018;9:58.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wang D, et al. Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation. Pulmonary Pharmacol Therapeut. 2019;58:101.
Article
CAS
Google Scholar
He H, et al. Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury. Cell Transplant. 2015;24(9):1699–715.
Article
PubMed
Google Scholar
Bastos AC, et al. Oral formulation angiotensin-(1–7) therapy attenuates pulmonary and systemic damage in mice with emphysema induced by elastase. Immunobiology. 2020;225(2):151893.
Article
CAS
PubMed
Google Scholar
Imai Y, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Magalhaes GS, et al. Activation of Ang-(1–7)/Mas receptor is a possible strategy to treat coronavirus (SARS-CoV-2) infection. Front Physiol. 2020;11:730.
Article
PubMed
PubMed Central
Google Scholar
Chappell MC, Al Zayadneh EM. Angiotensin-(1–7) and the regulation of anti-fibrotic signaling pathways. J Cell Signal. 2017;2(1):10.
Article
Google Scholar
Gironacci MM. Angiotensin-(1–7): beyond its central effects on blood pressure. Ther Adv Cardiovasc Dis. 2015;9(4):209–16.
Article
CAS
PubMed
Google Scholar
Wysocki J, et al. ACE and ACE2 activity in diabetic mice. Diabetes. 2006;55(7):2132–9.
Article
CAS
PubMed
Google Scholar
Wu YH, et al. The ACE 2 G8790A polymorphism: involvement in type 2 diabetes mellitus combined with cerebral stroke. J Clin Lab Anal. 2017;31(2):e22033.
Article
CAS
Google Scholar
Wang Z, et al. Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice. Biochem Biophys Res Commun. 2005;327(1):130–5.
Article
CAS
PubMed
Google Scholar
Möhlendick B, et al. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19. Pharmacogenet Genom. 2021;31:165–71.
Article
CAS
Google Scholar
Karakaş Çelik S, et al. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: a case study. J Med Virol. 2021;93(10):5947–52.
Article
PubMed
PubMed Central
CAS
Google Scholar
Gómez J, et al. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene. 2020;762:145102.
Article
PubMed
PubMed Central
CAS
Google Scholar
Verdecchia P, et al. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mehta P, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Akhmerov A, Marbán E. COVID-19 and the heart. Circ Res. 2020;126(10):1443–55.
Article
CAS
PubMed
Google Scholar
Hoffmann, M., et al., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181(2):271–280.e8.
Walls, A.C., et al., Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 2020;181(2): 281–292.e6.
Mahmood MS, et al. Association of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with essential hypertension. J Hum Hypertens. 2003;17(10):719–23.
Article
CAS
Google Scholar
Schüler R, et al. High-saturated-fat diet increases circulating angiotensin-converting enzyme, which is enhanced by the rs4343 polymorphism defining persons at risk of nutrient-dependent increases of blood pressure. J Am Heart Assoc. 2017;6(1):e004465.
Article
PubMed
PubMed Central
Google Scholar
Watanabe T, Barker TA, Berk BC. Angiotensin II and the endothelium: diverse signals and effects. Hypertension. 2005;45(2):163–9.
Article
CAS
PubMed
Google Scholar
Senchenkova EY, et al. Angiotensin II–mediated microvascular thrombosis. Hypertension. 2010;56(6):1089–95.
Article
CAS
PubMed
Google Scholar
Tay K-H, Lip GY. What “drives” the link between the renin–angiotensin–aldosterone system and the prothrombotic state in hypertension? Oxford: Oxford University Press; 2008.
Book
Google Scholar
Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol. 2020;146:32–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Biswas S, et al. Blood clots in COVID-19 patients: simplifying the curious mystery. Med Hypotheses. 2021;146:110371.
Article
CAS
PubMed
Google Scholar
Ferreira AJ, et al. New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1–7)/mas receptor axis. Int J Hypertens. 2012;2012:5.
Google Scholar
Tan WSD, et al. Targeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases. Curr Opin Pharmacol. 2018;40:9–17.
Article
CAS
PubMed
Google Scholar
Srivastava P, et al. Imbalance between Angiotensin II-Angiotensin (1–7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension. Diabetes Metab Syndr. 2019;13(3):2061–8.
Article
PubMed
Google Scholar
Cook JR, Ausiello J. Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19. Rev Endocrine Metabolic Disord. 2021;10:1–20.
Google Scholar
Lanza K, et al. Covid-19: the renin–angiotensin system imbalance hypothesis. Clin Sci. 2020;134(11):1259–64.
Article
CAS
Google Scholar
Killerby ME, et al. Characteristics associated with hospitalization among patients with COVID-19—Metropolitan Atlanta, Georgia, March–April 2020. Morb Mortal Wkly Rep. 2020;69(25):790.
Article
CAS
Google Scholar
Klein SL, et al. Biological sex impacts COVID-19 outcomes. PLoS Pathog. 2020;16(6):e1008570.
Article
CAS
PubMed
PubMed Central
Google Scholar